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In germ cells and the early embryo, the mammalian genome undergoes widespread epigenetic reprogramming.
Animal studies suggest that this process is vulnerable to external factors. We report two children who were conceived
by intracytoplasmic sperm injection (ICSI) and who developed Angelman syndrome. Molecular studies, including
DNA methylation and microsatellite and quantitative Southern blot analysis, revealed a sporadic imprinting defect
in both patients. We discuss the possibility that ICSI may interfere with the establishment of the maternal imprint
in the oocyte or pre-embryo.
Intracytoplasmic sperm injection (ICSI) was introduced
in 1992 as a solution for male infertility. Several studies
comparing ICSI to traditional in vitro fertilization have
established the general safety of ICSI (for review, see
Koulischer et al. [1997]). Schieve et al. (2002) reported
an excess risk of low and very low birth weight after
assisted reproduction, and Hansen et al. (2002) found
that ICSI is associated with an increased risk of major
birth defects. It has also been reported that there is a
slightly higher incidence of sex-chromosome aneuploidy
in ICSI, which, however, may be related to the under-
lying cause of the male infertility (Koulischer et al.
1997). Although most studies have compared the rates
of pregnancy and congenital anomalies, only a few have
analyzed developmental outcomes. In a case-control
study of a relatively small number of children (221 chil-
dren conceived by ICSI and 208 normally conceived chil-
dren), Sutcliffe et al. (2001) found no difference in de-
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velopmental level after 17 mo of follow-up. Here, we
report on two unrelated children who were conceived
by ICSI and found to have Angelman syndrome (AS
[MIM 105830]). In both cases, informed consent was
obtained from the parents.
AS is a neurogenetic disorder characterized by severe
mental retardation, delayed motor development, poor
balance accompanied by jerky movements, absence of
speech, and happy disposition. It is caused by loss of
function of the maternal allele of theUBE3A gene (MIM
601623) on chromosome 15, resulting from a deletion,
a point mutation, a uniparental paternal disomy, or an
imprinting defect (for review, see Nicholls and Knepper
2001). The last group of patients have a paternal imprint
on the maternal chromosome as a result of a sporadic
imprinting error or, less frequently, an inherited imprint-
ing-center (IC) deletion.
Patient 1 is a 3-year-old girl who was referred for
evaluation of global developmental delay, particularly in
speech, and hypotonia. She had poor balance, sleep dif-
ficulties, an overly happy personality, and no seizures.
Her developmental-age equivalent was 18 mo. She was
conceived by a 33-year-old mother and a 31-year-old
father, who sought ICSI because of oligospermia and de-
creased sperm motility. The pregnancy was uncompli-
cated. Previous investigations showed a normal 46,XX
karyotype and normal results on fragile X DNA test,
metabolic screen, and brain MRI. Results of the girl’s
physical examination were notable for macrosomia, obe-
sity, microbrachycephaly, AS-like facies, and a flexed-
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Figure 1 Molecular analysis. A, DNA was digested with XbaI
and NotI and was hybridized with a probe for SNRPN. A normal
control subject (C) and the parents of patient 1 (M1, mother; F1,
father) have a methylated maternal band (top of lane) and an un-
methylated paternal band (bottom of lane) of equal intensity. Patients
with AS and Prader-Willi syndrome (PWS) show only a single un-
methylated or methylated band, respectively. Patient 2 shows an un-
methylated band only. Patient 1 shows a very faint methylated band,
in addition to the unmethylated band (increased intensity). Similar
results were obtained by methylation-specific PCR (data not shown).
B, IC deletion analysis. DNA was digested with EcoRV and was hy-
bridized with a probe for the AS element of the IC (IC1/3; upper band)
(Schumacher et al. 1998) and a probe for theRB1 gene on chromosome
13 (lower band). The relative hybridization intensities, as determined
by scanning densitometry, are given below each lane. A deletion patient
(DEL) has a reduced signal ratio. The two patients described in the
present report (1 and 2) have a ratio similar to that of a normal control
subject (i.e., no IC deletion). Similar results were obtained in a second,
independent experiment (data not shown).
arm posture. Results of chromosome 15 FISH study,
with the use of the SNRPN probe (MIM 182279), and
uniparental disomy analysis, with the use of microsat-
ellite markers, were normal in blood lymphocytes and
cultured skin fibroblasts (data not shown). However, the
chromosome 15 methylation pattern obtained by South-
ern blotting with the use of the SNRPN probe was ab-
normal, revealing a strong unmethylated band and a
faint methylated band, which was 10% of the total in-
tensity by densitometry (fig. 1A). A similar pattern was
seen in the patient’s fibroblasts (data not shown). Meth-
ylation-specific PCR of exon 1 of the SNRPN gene (Zes-
chnigk et al. 1997) also revealed a strong unmethylated
and a weak methylated band (data not shown). Con-
sistent results of the mosaic methylation pattern in this
patient were obtained by two independent studies on a
second blood sample, as well as on a repeated fibroblast
culture, using both methods (data not shown). Results
of parental chromosome analyses were normal, as was
the mother’s chromosome 15 methylation pattern.
Quantitative Southern blot analysis (fig. 1B), as well as
sequence analysis of the 880-bp AS-IC element did not
reveal any IC mutation.
Patient 2 is a 32-mo-old girl who was referred for
evaluation of mental retardation and developmental de-
lays, especially in speech. She vomited frequently as an
infant and was hyperactive and very friendly. Results of
her physical examination were notable for microbrachy-
cephaly, broad mouth, prognathism, normal pigmenta-
tion, ataxic gait, and hypotonia of the trunk. Electro-
encephalogram revealed periods of generalized slow
activity and epileptiform activity. Her speech consisted
of single sounds and no words. She was conceived by a
31-year-old mother and 32-year-old father, who sought
ICSI because of oligospermia secondary to hypogona-
dotrophic hypogonadism. Pregnancy and birth were un-
complicated. The patient and her parents had normal
chromosomes. FISH studies with probes forD15S10 and
SNRPN, as well as microsatellite studies, revealed nor-
mal chromosomes of biparental origin (data not shown).
Methylation analysis showed an unmethylated band
only by Southern blotting with the SRNPN probe (fig.
1A) and by methylation-specific PCR (data not shown).
As in patient 1, no evidence for an IC mutation was
found (fig. 1B).
In normal individuals, the maternal SNRPN allele is
methylated, and the paternal allele is unmethylated. Hy-
pomethylation of the SNRPN locus in the two patients
indicates that they have a sporadic imprinting defect on
the maternal chromosome. Our findings raise the ques-
tion of whether the imprinting defect in the two chil-
dren conceived by ICSI is a coincidence or is causally
related to the technique of ICSI. We are well aware
that we cannot exclude other factors, such as environ-
mental agents or a defect related to male infertility, but
the assumption of a causal relationship is not unreason-
able for the following reasons:
1. AS is a rare disease that affects∼1/15,000 newborns.
Imprinting defects account for !5% of all cases (i.e.,
their incidence is 1/300,000 newborns). Although we
have found two such patients conceived by ICSI, we have
not found any ICSI child who has AS because of a de-
letion 15q, which is the most frequent cause of AS
(70%). This may suggest an overrepresentation of AS
imprinting defects among children conceived by ICSI.
Although a recent study of 92 ICSI cases found no ab-
normal methylation of chromosome 15, such a small
sample size does not exclude the possibility of a small
but increased risk (Manning et al. 2000).
2. As was shown by El-Maarri et al. (2001), the ma-
ternal methylation imprint on human chromosome 15
is not established before ovulation but only at or after
fertilization. Most, if not all, sporadic AS imprinting
defects occur at this time (Buiting et al. 1998). The lack
of an IC mutation in the two patients and the detection
of a mosaic methylation pattern in patient 1 make an
inherited defect unlikely and point to a postzygotic epi-
genetic defect, although a postzygotic gain of methyla-
tion in some cells can not be excluded.
3. ICSI bypasses many of the normal steps involved in
fertilization and activation of the oocyte. In addition,
ICSI causes other changes (e.g., the introduction of the
acrosome and its digestive enzymes into the ooplasm).
Furthermore, the oocyte undergoes mechanical stress,
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which may damage certain intracellular structures. The
true impact on fertilization is unknown, but only 50%
of ICSI conceptions are successful in humans, and animal
studies indicate that other abnormalities may occur, in-
cluding an alteration in calcium oscillations and delayed
decondensation of sperm chromosomes. It is possible
that ICSI disrupts the production or function of trans-
acting factors or local structures necessary for imprinting
of the maternal chromosome 15.
4. Young et al. (2001) have shown that under certain
conditions the in vitro culture of sheep pre-embryos that
were fertilized in vivo can lead to fetal overgrowth.
Those authors found that the overgrowth is associated
with hypomethylation of the imprinting control element
of the maternal Igf2r allele. Their data demonstrate that
maternal imprinting in the pre-embryo is vulnerable to
external factors.
In summary, there are some indications that ICSI
might interfere with the establishment of the maternal
imprint in the oocyte or pre-embryo and increase the
risk of imprinting defects. We suggest addressing this
question in a long-term follow-up study of a large cohort
of children. One may also consider performing a pre-
natal methylation test for all known imprinted loci in
fetuses conceived by ICSI.
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